Skip to content
10-Q

Quarterly Report

OMNI BIO PHARMACEUTICAL, INC.

0001437749-14-020713

← back to feed
Filed
Nov 14, 2014 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · Nov 13, 2014 39.11M sh
Operating Cash Flow Q2 2015 · Sep 30, 2014 −$1.06M
Operating Cash Flow Q2 2015 · Sep 30, 2013 −$924.42K
Cash And Equivalents Q2 2015 · Sep 30, 2014 $709.92K
Cash And Equivalents Q2 2015 · Mar 31, 2014 $271.43K
Cash And Equivalents Q2 2015 · Sep 30, 2013 $780.25K
Cash And Equivalents Q2 2015 · Mar 31, 2013 $343.28K
Stockholders Equity Q2 2015 · Sep 30, 2014 −$1.86M
Stockholders Equity Q2 2015 · Jun 30, 2014 −$981.82K
Stockholders Equity Q2 2015 · Mar 31, 2014 −$884.26K
Stockholders Equity Q2 2015 · Dec 31, 2013 −$884.26K
Current Liabilities Q2 2015 · Sep 30, 2014 $2.22M
Current Liabilities Q2 2015 · Mar 31, 2014 $96.34K
Total Liabilities Q2 2015 · Sep 30, 2014 $2.82M
Total Liabilities Q2 2015 · Mar 31, 2014 $1.38M
Current Assets Q2 2015 · Sep 30, 2014 $820.94K
Current Assets Q2 2015 · Mar 31, 2014 $303.63K
Total Assets Q2 2015 · Sep 30, 2014 $959.27K
Total Assets Q2 2015 · Mar 31, 2014 $496.98K
Sga Expense Q2 2015 · Sep 30, 2014 $475.07K
Sga Expense Q2 2015 · Sep 30, 2014 $788.05K
Sga Expense Q2 2015 · Sep 30, 2013 $539.58K
Sga Expense Q2 2015 · Sep 30, 2013 $1.04M
Rd Expense Q2 2015 · Sep 30, 2014 $138.44K
Rd Expense Q2 2015 · Sep 30, 2014 $358.78K
Rd Expense Q2 2015 · Sep 30, 2013 $98.75K
Rd Expense Q2 2015 · Sep 30, 2013 $126.59K
Net Income Q2 2015 · Sep 30, 2014 −$989.65K
Net Income Q2 2015 · Sep 30, 2014 −$1.82M
Net Income Q2 2015 · Jun 30, 2014 −$833.7K
Net Income Q2 2015 · Sep 30, 2013 −$639.98K
Net Income Q2 2015 · Sep 30, 2013 −$1.32M
Operating Income Q2 2015 · Sep 30, 2014 −$613.51K
Operating Income Q2 2015 · Sep 30, 2014 −$1.15M
Operating Income Q2 2015 · Sep 30, 2013 −$638.33K
Operating Income Q2 2015 · Sep 30, 2013 −$1.17M